Characterization of rat exploratory behavior using the exploration box test

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 19, Issue 10, 1997, Pages 683-691

  Otter, Margareete Helge ^a   Matto, Vallo ^a   Sõukand, Renate ^a   Skrebuhhova, Tatjana ^a   Allikmets, Lembit ^a   Harro, Jaanus ^a  

^a UNIVERSITY OF TARTU   (Estonia)

Author keywords

Anxiogenics; Anxiolytics; Exploratory behavior; Rats

Indexed keywords

BUSPIRONE; DEXAMPHETAMINE; DIAZEPAM; GEPIRONE; N METHYL BETA CARBOLINE 3 CARBOXAMIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; EXPLORATORY BEHAVIOR; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; RAT; REARING; SUBCUTANEOUS DRUG ADMINISTRATION; TRANQUILIZING ACTIVITY;

AMPHETAMINE; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BEHAVIOR, ANIMAL; BUSPIRONE; CARBOLINES; DIAZEPAM; DOSE-RESPONSE RELATIONSHIP, DRUG; EXPLORATORY BEHAVIOR; FEMALE; MALE; PYRIMIDINES; RATS; RATS, WISTAR;

EID: 0031422452     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Harro, J. Measurement of exploratory behavior in rodents. In: Methods in Neurosciences, Vol. 14. Conn, P.M. (Ed.). Academic Press: San Diego 1993, 359-77.
2. Crawley, J.N. Exploratory behavior models of anxiety in mice. Neurosci Biobehav Rev 1985, 9: 37-44.
3. Walsh, R.N., Cummins, R.A. The open field test: A critical review. Psychol Bull 1976, 83: 482-504.
4. Lister, R.G. Ethologically-based animal models of anxiety disorders. Pharmacol Ther 1990, 46: 321-40.
5. Belzung, C., LePape, G. Comparison of different behavioral test situations used in psychopharmacohgy for measurement of anxiety. Physiol Behav 1994, 56: 623-8.
6. Rodgers, R.J., Johnson, N.J.T. Factor analysis of spatiotemporal and ethological measures in the marine elevated plusmaze test of anxiety. Pharmacol Biochem Behav 1995, 52: 297-303.
7. Vivian, J.A., Farrell, W.J., Sapperstein, S.B., Miczek, K.A. Diazepam withdrawal: Effects ofdiazepam and gepirone on acoustic startle-induced 22 kHz ultrasonic vocalizations. Psychopharmacology 1994, 114: 101-8.
8. Harro, J., Oreland, L., Vasar, E., Bradwejn, J. Impaired exploratory behavior after DSP-4 treatment in rats: implications for the increased anxiety after noradrenergic denervation. Eur Neuropsychopharmacol 1995, 5: 447-55.
9. Soderpalm, B., Blomqvist, O., Engel, J.A. Clonidine-induced "anxiolysis" persists after depletion of brain noradrenaline. 13th Winter Conference on Brain Research (March 13-20, La Plagne) 1993.
10. File, S.E., Pellow, S. The anxiogenicaction of FG 7142 in the social interaction test is reversed by chlordiazepoxide and Ro 15-1788 but not by CG.S 8216. Arch Int Pharmacodyn Ther 1984, 271: 198-205.
11. Dorow, R., Horowski, R., PascheLke, G., Amin, M., Braestrup, C. Severe anxiety induced by FG-7142, a β-carboline ligand for benzodiazepine receptors. Lancet 1983, 9: 98-9.
12. Leidenheimer, N.J., Schechter, M.D. Discriminative stimulus control by the anxiogenic β-carboline FG 7142: Generalization to a physiological stressor. Pharmacol Biochem Behav 1988, 30: 351-5.
13. Fellow, S., File, S.E. The effects of putative anxiogenic compounds (FG 7142, CGS 8216 and Ro 15-1788) on the rat corticosterone response. Physiol Behav 1985, 35: 587-90.
14. Treit, D. Animal models for the study of anti-anxiety agents: a review. Neurosci Biobehav Rev 1985 9: 203-22.
15. 1A ligands. 8-OH-DPAT and MDL 73005EF, in mice. Neuroreport 1990, 1: 267-70.
16. Renner, M.J. Neglected aspects of exploratory and investigatory behavior. Psychobiology 1990, 18: 16-22.